A Single-Centre, Single Dose, Randomized,Open Label, Exploratory, 5-Way Crossover Study Evaluating the Pharmakokinetic Profiles of Various Egalet Hydrocodone Formulations In Healthy Volunteers Under Fasting Conditions.

Trial Profile

A Single-Centre, Single Dose, Randomized,Open Label, Exploratory, 5-Way Crossover Study Evaluating the Pharmakokinetic Profiles of Various Egalet Hydrocodone Formulations In Healthy Volunteers Under Fasting Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Hydrocodone (Primary) ; Hydrocodone/paracetamol
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Egalet
  • Most Recent Events

    • 18 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top